Key result
Overexpression of mutant human IGFBP-2 decreased body weight, longitudinal growth, and lean body mass, but increased relative fat mass in both genders (p < 0.05).
Why the study?
Does overexpression of HBD1-deficient human IGFBP-2 affect growth, fat mass accretion, and food intake in mice?
Does overexpression of HBD1-deficient human IGFBP-2 affect growth, fat mass accretion, and food intake in mice?
Overexpression of HBD1-deficient human IGFBP-2 in mice reduces lean body mass and longitudinal growth while increasing relative fat mass and exerting gender-specific effects on food intake.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for IGFBP-2 in murine body composition; human relevance and mechanisms remain to be tested.
IGFBP-2 affects growth and metabolism and is thought to impact on energy homeostasis and the accretion of body fat via its heparin binding domains (HBD). In order to assess the function of the HBD present in the linker domain (HBD1) we have generated transgenic mice overexpressing mutant human IGFBP-2 lacking the PKKLRP sequence and carrying a PNNLAP sequence instead. Transgenic mice expressed high amounts of human IGFBP-2, while endogenous IGFBP-2 or IGF-I serum concentrations were not affected. In both genders we performed a longitudinal analysis of growth and metabolism including at least 4 separate time points between the age of 10 and 52 weeks. Body composition was assessed by nuclear magnetic resonance (NMR) analysis. Food intake was recorded by an automated online-monitoring. We describe negative effects of mutant human IGFBP-2 on body weight, longitudinal growth and lean body mass (p < 0.05). Very clearly, negative effects of mutant IGFBP-2 were not observed for fat mass accretion throughout life. Instead, relative fat mass was increased in transgenic mice of both genders (p < 0.05). In male mice transgene expression significantly increased absolute mass of total body fat over all age groups (p < 0.05). Food intake was increased in female but decreased in male transgenic mice at an age of 11 weeks. Thus our study clearly provides gender- and time-specific effects of HBD1-deficient hIGFBP-2 (H1d-BP-2) on fat mass accretion and food intake. While our data are in principal agreement with current knowledge on the role of HB-domains for fat accretion we now may also speculate on a role of HBD1 for the control of eating behavior.
No takes yet. Share an insight, caveat, or question.
Wiedmer et al. (2015) studied this question. Overexpression of mutant human IGFBP-2 lacking the PKKLRP sequence (H1d-BP-2) vs. Non-transgenic mice was evaluated on Body weight, longitudinal growth, lean body mass, and fat mass accretion (p=<0.05). Overexpression of mutant human IGFBP-2 decreased body weight, longitudinal growth, and lean body mass, but increased relative fat mass in both genders (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: